Meeting the challenges and burdens associated with hereditary angioedema

Managed Care

Volumn 20, Issue 9, 2011, Pages 44-51

  Toscani, Michael ^a   Riedl, Marc ^b   Geffen, David ^b  

^a JEFFERSON COLLEGE OF POPULATION HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Economic burden; Hereditary angioedema; Humanistic burden

Indexed keywords

ANGIONEUROTIC EDEMA; ARTICLE; COST OF ILLNESS; DISEASE MANAGEMENT; ECONOMICS; HEALTH SURVEY; HUMAN; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANGIOEDEMAS, HEREDITARY; COST OF ILLNESS; DISEASE MANAGEMENT; HEALTH SURVEYS; HUMANS;

EID: 80055093707     PISSN: 10623388     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (35)

1. Berinert [prescribing information]. Kankakee, IL: CSL Behring LLC; 2009.
2. Blaustein MB, Vernon MK, et al. Healthrelated quality of life burden associated with androgen therapies for hereditary angioedema. Poster presented at: American College of Allergy, Asthma & Immunology Annual Meeting; November 2008; Seattle, WA.
3. Bork K, Barnstedt SE, Koch P, Traupt H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356(9225):213-217.
4. Bork K, Gül D, Dewald G. Hereditary angioedema with normal C1 inhibitor in a family with affected women and men. Br J Dermatol. 2006;154(3): 542-545.
5. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267-274.
6. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):24.
7. Bygum A, Andersen KE, Mikkelsen CS. Self-administration of intravenous C-1 inhibitor therapy for hereditary angioedema and associated quality life benefits. Eur J Dermatol. 2009; (2):147-151.
8. Chen H, Blanc PD, Hayden ML, et al, TENOR Study Group. Assessing productivityloss and activity impairment in severe or difficult-to-treat asthma. Value Health. 2008;11(2): 231-239.
9. Cinryze [prescribing information]. New York: Lev Pharmaceuticals, Inc; 2008
10. Davis AE, III. C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol. 1988;6:595-628.
11. Davis AE, III. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am. 2006;26(4):633-651.
12. Davis AE, III. The pathophysiology of hereditary angioedema. Clin Immunol. 2005;114(1):3-9.
13. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1-esterase. Am J Med. 1963;35:37-44.
14. Duan QL, Binkley K, Rouleau GA. Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema. J Allergy Clin Immunol. 2009;123(4):906-910.
15. European Medicines Agency. Evaluation of Medicines for Human Use: Refusal CHMP Assessment Report for Rhucin. London, England; 2008. Doc. Ref.: EMEA/CHMP/116287/2008.
16. Farkas H, Jakab L, Temesszentandrási G, et al. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol. 2007;120(4):941-947.
17. Firazyr [summary of product characteristics]. Lapheim, Germany: Rentschler Biotechnologie GmbH; 2008.
18. Gompels MM, Lock RJ, Abinum M, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139(3):379-394.
19. Kalbitor [prescribing information]. Cambridge, MA: Dyax Corp; 2009.
20. Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol. 2002;109(2):195-209.
21. Kreuz W, Martinez-Saguer I, Aygören-Pürsün E, Rusicke E, Heller C, Klingebiel T. C-1 inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Transfusion. 2009;49: 1987-1995.
22. Levy JH, O'Donnell PS. The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin Investig Drugs. 2006;15(9): 1077-1090.
23. Lumry WR, Castaldo AJ, Vernon MK, et al. The humanistic burden of hereditaryangioedema: impact on healthrelated quality of life, productivity, and depression. Allergy Asthma Proc. 2010;31(5):407-414.
24. Nussberger J, Cugno M, Cicardi M, Agostoni A. Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol. 1999;104(6):1321-1322.
25. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161(20):2417-2429.
26. Prematta MJ, Prematta T, Craig TJ. Treatment of hereditary angioedema with plasma derived C1 inhibitor. Ther Clin Risk Manag. 2008;4(5):975-982.
27. Reilly MC, Gerlier L, Brabant Y, Brown M. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease. Clin Ther. 2008;30 (2):393-404.
28. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, López-Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Clin Immunol. 2005;94 (4):498-503.
29. Rosen FS, Austen KF. The neurotic edema. N Engl J Med. 1969;280(24):1356-1357.
30. Schmaier AH. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system. Int Immunopharmacol. 2008;8(2):161-165.
31. Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE III. Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing actvities. Clin Exp Immunol. 1994;95(1):22-28.
32. Ware JE Jr, Kosinski M, Turner-Bowker D, Gandek B. How to score version 2 of the SF-12 Health Survey (with a supplement documenting version 1). Lincoln, RI: QualityMetric, Inc; 2002.
33. Wilson DA, Bork, K, Shea EP, Rentz AM, Blaustein MB, Pullman WE. Economic costs associated with acute attacks and long-term management of hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104(4):314-320.
34. Zilberberg MD, Jacobsen T, Tillotson G. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007. Allergy Asthma Proc. 2010;31(6)511-519.
35. Zuraw BL. Clinical practice. hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036.